OUTCOMES FOR BREAST CANCER

Return to Outcomes Home Page

5-Year Survival Rate for Breast Cancer Patients (updated Nov 2012)

DeKalb Surgical Associates has implemented a method of continuous outcomes assessment for a variety of clinical indicators. One of these indicators looks at the long-term survival of patients with breast cancer. Overall five year survival for our breast cancer patients is almost 84%. This seems like a fairly significant improvement over our five year survival rates from an earlier time frame, as shown below for patients diagnosed in 1997-98 when the overall survival was about 78%. These rates can vary a bit up and down from one time frame to another without necessarily being significant, but it is certainly encouraging, and the national data shows a similar higher overall survival rate, increasing from about 76% to about 85%.

This data has been compared to published data from the National Cancer Data Bank, and is shown below, and includes patients from 2003-05. For a more homogeneous comparison, the data is shown by individual stages. Our results are equivalent to national data. The slight differences in 5 year survival (higher for Stage III, and lower for Stage II) are not statistically significantly different from the national data. These differences can occur for a variety of reasons, including differences in the patient populations. Older outcomes comparison data is shown below in green font, for reference.

outcomes-breast-cancer-1

outcomes-breast-cancer-2

outcomes-breast-cancer-3

5-Year Survival Rate for Breast Cancer Patients (updated Feb 2012)

DeKalb Surgical Associates has implemented a method of continuous outcomes assessment for a variety of clinical indicators. One of these indicators looks at the long-term survival of patients with breast cancer. Overall five year survival for our breast cancer patients is almost 83%. This seem like a fairly significant improvement over our five year survival rates from an earlier time frame, as shown below for patients diagnosed in 1997-98 when the overall survival was about 78%. These rates can vary a bit up and down from one time frame to another without necessarily being significant, but it is certainly encouraging, and the national data shows a similar higher overall survival rate, increasing from about 76% to 85%

This data has been compared to published data from the National Cancer Data Bank, and is shown below, and includes patients from 2003-04. Our results are equivalent to national data.

Comparisons by stage 2 and 3 are shown separately below, and our rates are statistically the same as nationally reported survival rates.

outcomes-breast-cancer-4

outcomes-breast-cancer-5

outcomes-breast-cancer-6

outcomes-breast-cancer-7

These are results from older analyses, for comparison. the graph to the right shows overall survival as reported in 2005, for women diagnosed in 1997-98. Data for patients with Stage II breast cancer from 1997-98 shows similar results for this sub-group. This was the most recent data available at the time for looking at 5-year survival rates. The national data shown (NCDB, which stands for “National Cancer Data Base”) is from 1995-96. The other comparison was with all other Stage II breast cancer patients treated at DeKalb Medical Center during the 1997-98 time period. The 5-year survival for our patients was 87% compared with 80% for all other patients at DeKalb Medical Center.

outcomes-breast-cancer-8

Go to top of page